NGEN

$4.04

Market ClosedAs of Mar 17, 8:00 PM UTC

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Recent News

Simply Wall St.
Feb 1, 2026

When Will NervGen Pharma Corp. (CVE:NGEN) Breakeven?

We feel now is a pretty good time to analyse NervGen Pharma Corp.'s ( CVE:NGEN ) business as it appears the company may...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.